Radiohead’s Ed O’Brien Announces ‘An Evening With… Blue Morpho’ 2026 UK and European Tour with Dave Okumu and ESKA

Why It Matters

The tour underscores O'Brien’s successful transition from Radiohead guitarist to solo artist, expanding his brand and generating new revenue streams in the competitive live‑music market. It also signals a broader trend of established band members leveraging solo projects to diversify their audiences.

Key Takeaways

• Seven‑date European tour starts Oct 4 in Amsterdam
• Blue Morpho album releases May 22, 2026
• Dave Okumu and ESKA join as live collaborators
• Shows prioritize immersive, evolving performances, not studio replication
• Tickets go on sale April 2, 2026, 10 am local

Pulse Analysis

Ed O'Brien’s solo trajectory has accelerated since his 2020 debut, Earth, positioning him as a credible solo act separate from Radiohead’s legacy. Blue Morpho, his sophomore effort, blends hypnotic psych‑folk with trip‑hop textures, reflecting a period of personal challenge and artistic rebirth. By aligning the album launch with a concise European circuit, O'Brien maximizes media buzz while offering fans a fresh, narrative‑driven concert experience that leverages his reputation for sonic experimentation.

The tour’s itinerary—Amsterdam, Milan, Paris, Berlin, Hamburg, Groningen, and a London Barbican finale—targets major cultural hubs with strong ticket‑selling histories. Partnering with musical director Dave Okumu, known for his Mercury‑prize‑nominated work, and versatile vocalist ESKA adds credibility and draws cross‑genre interest. Emphasizing fluid set‑lists and improvisational moments differentiates the shows from typical album‑tour formats, appealing to concertgoers seeking unique, one‑off performances. Early ticket sales, slated for April 2, are expected to benefit from both Radiohead fans and new listeners attracted by the collaborators’ followings.

Industry analysts view O'Brien’s move as part of a larger pattern where members of iconic bands launch solo ventures to diversify income and maintain relevance between group cycles. Live‑music revenue continues to rebound post‑pandemic, and intimate, artist‑curated tours like this can command premium pricing while fostering deeper fan connections. Moreover, O'Brien’s hints about Radiohead’s future continental touring schedule suggest a strategic balance: solo projects sustain momentum while the band prepares a staggered global presence, ensuring continuous engagement across multiple market segments.